Benazepril hydrochloride

151 BLCL

2-Hydrazinyl-4-phenylthiazole hydrochloride.

215 BLCL

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Biochem/physiol Actions Benazepril is a long-acting angiotensin converting enzyme (ACE) inhibitor. Features and Benefits This compound was developed by Novartis .

Biochem/physiol Actions Benazepril is a long-acting angiotensin converting enzyme (ACE) inhibitor. Features and Benefits This compound was developed by Novartis .

General description Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards Application

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Benazolin Standard

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the